Capital Flow Monitor · Sponsors · CIK 1979709
Apogem Secondary Fund VII, LP
299 PARK AVENUE, NEW YORK, NY, 10171 · 212-601-3614
Pooled Investment Fund / Private Equity Fund · Limited Partnership· inc. DELAWARE true 2023
Fit score
—
Offering
$1.3B
Sold
$1.21B
% sold
93.4%
Investors
86
Min investment
$1.0M
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-02-13 | D/A ·current | 506(b) | $1.3B | $1.21B | 93.4% | 86 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- N/A ASF VII GP, LLC — Director, New York, NY
- John M Grady — Executive Officer, New York, NY
- Christopher Stringer — Executive Officer, New York, NY
- N/A Apogem Capital LLC — Promoter, New York, NY
- Michael Zeleniuch — Executive Officer, New York, NY
- Michael Griech — Executive Officer, New York, NY
Placement agents
- Nylife Distributors Llc · 0 RE raises
- Alvine Capital Management Limited · 0 RE raises
- Alvine Capital Ab (acab) · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.